Key Details
Price
$0.74Annual Revenue
$8.01 MAnnual EPS
-$1.06Annual ROE
-66.50%Beta
0.12Events Calendar
Next earnings date:
Jan 02, 2025Recent quarterly earnings:
Nov 13, 2023Recent annual earnings:
Mar 09, 2021Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
July 05, 2022Analyst ratings
Recent major analysts updates
16 Aug '22 HC Wainwright & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Fresh Tracks Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Fresh Tracks Therapeutics Announces Delaware Petition Filed Seeking Appointment of Custodian for Eventual Dissolution of Company
FRTX
globenewswire.com17 June 2024
Company filed an answer in overall agreement with petition on June 14, 2024 and awaits a hearing date from the Delaware Chancery Court Company filed an answer in overall agreement with petition on June 14, 2024 and awaits a hearing date from the Delaware Chancery Court
FAQ
- What is the primary business of Fresh Tracks Therapeutics?
- What is the ticker symbol for Fresh Tracks Therapeutics?
- Does Fresh Tracks Therapeutics pay dividends?
- What sector is Fresh Tracks Therapeutics in?
- What industry is Fresh Tracks Therapeutics in?
- What country is Fresh Tracks Therapeutics based in?
- When did Fresh Tracks Therapeutics go public?
- Is Fresh Tracks Therapeutics in the S&P 500?
- Is Fresh Tracks Therapeutics in the NASDAQ 100?
- Is Fresh Tracks Therapeutics in the Dow Jones?
- When was Fresh Tracks Therapeutics's last earnings report?
- When does Fresh Tracks Therapeutics report earnings?
- Should I buy Fresh Tracks Therapeutics stock now?
What is the primary business of Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics (FRTX) is a biopharmaceutical company focused on developing innovative treatments for patients with serious health conditions. They aim to improve patient outcomes through advanced therapies, particularly in areas with high unmet medical needs. Their work combines science and compassion to enhance healthcare solutions.
What is the ticker symbol for Fresh Tracks Therapeutics?
The ticker symbol for Fresh Tracks Therapeutics is NASDAQ:FRTX
Does Fresh Tracks Therapeutics pay dividends?
No, Fresh Tracks Therapeutics does not pay dividends
What sector is Fresh Tracks Therapeutics in?
Fresh Tracks Therapeutics is in the Healthcare sector
What industry is Fresh Tracks Therapeutics in?
Fresh Tracks Therapeutics is in the Biotechnology industry
What country is Fresh Tracks Therapeutics based in?
Fresh Tracks Therapeutics is headquartered in United States
When did Fresh Tracks Therapeutics go public?
Fresh Tracks Therapeutics's initial public offering (IPO) was on 10 March 1993
Is Fresh Tracks Therapeutics in the S&P 500?
No, Fresh Tracks Therapeutics is not included in the S&P 500 index
Is Fresh Tracks Therapeutics in the NASDAQ 100?
No, Fresh Tracks Therapeutics is not included in the NASDAQ 100 index
Is Fresh Tracks Therapeutics in the Dow Jones?
No, Fresh Tracks Therapeutics is not included in the Dow Jones index
When was Fresh Tracks Therapeutics's last earnings report?
Fresh Tracks Therapeutics's most recent earnings report was on 13 November 2023
When does Fresh Tracks Therapeutics report earnings?
The next expected earnings date for Fresh Tracks Therapeutics is 2 January 2025
Should I buy Fresh Tracks Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions